VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,531,682 | -11.4% | 725,815 | -0.9% | 1.08% | -9.4% |
Q2 2023 | $22,050,005 | +91844.0% | 732,315 | -1.2% | 1.19% | -11.5% |
Q1 2023 | $23,982 | +13.3% | 741,332 | +0.4% | 1.34% | +6.1% |
Q4 2022 | $21,159 | -99.9% | 738,277 | -50.5% | 1.26% | +9.2% |
Q3 2022 | $35,956,000 | +73.6% | 1,490,750 | +97.0% | 1.16% | -5.5% |
Q2 2022 | $20,715,000 | -28.1% | 756,591 | +0.8% | 1.23% | -15.7% |
Q1 2022 | $28,797,000 | +23.5% | 750,901 | +3.1% | 1.45% | +30.5% |
Q4 2021 | $23,324,000 | +8.6% | 728,201 | -0.1% | 1.11% | -3.3% |
Q3 2021 | $21,483,000 | -11.7% | 728,964 | +1.8% | 1.15% | -9.5% |
Q2 2021 | $24,332,000 | +2.7% | 716,059 | -1.8% | 1.27% | -3.3% |
Q1 2021 | $23,699,000 | -9.2% | 729,212 | +0.6% | 1.32% | -17.5% |
Q4 2020 | $26,097,000 | -11.2% | 724,512 | -3.5% | 1.60% | -21.7% |
Q3 2020 | $29,401,000 | -1.0% | 750,789 | -7.2% | 2.04% | -5.4% |
Q2 2020 | $29,685,000 | +53.6% | 809,290 | -3.5% | 2.15% | +32.6% |
Q1 2020 | $19,321,000 | -22.4% | 838,595 | -1.4% | 1.62% | -3.7% |
Q4 2019 | $24,898,000 | +10.7% | 850,330 | +0.9% | 1.69% | -0.1% |
Q3 2019 | $22,501,000 | +1.3% | 842,402 | -3.1% | 1.69% | +1.9% |
Q2 2019 | $22,221,000 | +15.7% | 869,352 | +1.5% | 1.66% | +16.6% |
Q1 2019 | $19,200,000 | +5.7% | 856,367 | -0.5% | 1.42% | -3.4% |
Q4 2018 | $18,160,000 | -8.6% | 861,092 | -19.7% | 1.47% | +5.8% |
Q3 2018 | $19,868,000 | +9.6% | 1,072,770 | +32.1% | 1.39% | -0.2% |
Q2 2018 | $18,121,000 | +2.4% | 812,220 | +0.8% | 1.39% | +0.2% |
Q1 2018 | $17,703,000 | -0.4% | 805,420 | +5.3% | 1.39% | +0.7% |
Q4 2017 | $17,773,000 | -0.4% | 764,770 | -1.6% | 1.38% | -5.4% |
Q3 2017 | $17,853,000 | +6.2% | 777,570 | +2.1% | 1.46% | +1.7% |
Q2 2017 | $16,815,000 | -1.8% | 761,570 | +1.5% | 1.43% | -6.4% |
Q1 2017 | $17,120,000 | +0.8% | 750,540 | -7.5% | 1.53% | -6.1% |
Q4 2016 | $16,977,000 | +15.8% | 811,515 | +46.3% | 1.63% | +11.3% |
Q3 2016 | $14,661,000 | -5.3% | 554,715 | -0.7% | 1.46% | -9.7% |
Q2 2016 | $15,483,000 | +33.9% | 558,765 | -3.5% | 1.62% | +29.7% |
Q1 2016 | $11,563,000 | – | 579,015 | – | 1.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |